Stay updated on Secukinumab in AS: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in AS: Clinical Trial page.

Latest updates to the Secukinumab in AS: Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check8 days agoChange DetectedThe completed secukinumab trial record is now displayed, including its study design, measured outcomes, locations, publications, and participant-data sharing information, in place of a 403 error page.SummaryDifference93%

- Check15 days agoChange DetectedThe site footer now shows revision v3.8.0 instead of v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH transition notice appears above the ClinicalTrials.gov 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study content with an access notice. This indicates an access restriction rather than an update to the study details or related information.SummaryDifference18%

Stay in the know with updates to Secukinumab in AS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in AS: Clinical Trial page.